PT  - JOURNAL ARTICLE
AU  - John Nixon
AU  - Claire McHugh
AU  - Sam Jones
TI  - Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston, Lancashire
AID  - 10.7861/clinmedicine.13-4-358
DP  - 2013 Aug 01
TA  - Clinical Medicine
PG  - 358--361
VI  - 13
IP  - 4
4099  - http://www.rcpjournals.org/content/13/4/358.short
4100  - http://www.rcpjournals.org/content/13/4/358.full
SO  - Clin Med2013 Aug 01; 13
AB  - Neuromuscular disease is one of the most common indications for the use of intravenous immuno-globulin (IVIG). We describe practical aspects of IVIG administration and dosing in long-term treatment, as well as the setting up of a day-case service in a regional neurology unit to provide a streamlined patient experience. An audit of the safety of IVIG administration and patient satisfaction during implementation supported the fact that this is a relatively safe treatment. Standardised assessment methods have been used both to monitor treatment effect and to provide the necessary outcome measures for Department of Health (DOH) monitoring of IVIG use.